BioCardia CEO Buys Shares Amid Low Valuation, Investor Hope Persists
BioCardia insider buying shows confidence, but the CEO’s purchases may not lift the stock until CardiAMP HF trials and new partnerships deliver results.
3 minutes to read
BioCardia Inc